Sponsors
Latest actions
Senate: Senate sustained Governor's veto
Senate: Requires 2/3 members present
Senate: Passed in enrolled form rejected (21-Y 18-N)
Governor: Vetoed by Governor
Governor: Governor's Action Deadline 11:59 p.m., April 8, 2024
Senate: Enrolled Bill Communicated to Governor on March 11, 2024
Senate: Signed by President
House: Signed by Speaker
Senate: Bill text as passed Senate and House (SB274ER)
Senate: Enrolled
Common questions
- What is SB274?
- SB274 is a bill in the Virginia Legislature (2024 Regular Session): Prescription Drug Affordability Board; established, drug cost affordability review, report.
- What is the status of SB274?
- Vetoed as of April 17, 2024. Latest action: Senate: Senate sustained Governor's veto (April 17, 2024).
- Who sponsored SB274?
- Jennifer D. Carroll Foy (D, 33), with 4 co-sponsors.
- Where is the official record for SB274?
- On the Virginia Legislature website: https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB274
Source: official Virginia record. Tracked by Delilah, AI for legislation across all 50 states and Congress.


